|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baba Y, Yagi T, Sawayama H, Hiyoshi Y,
Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N and Baba H: Long
interspersed element-1 methylation level as a prognostic biomarker
in gastrointestinal cancers. Digestion. 97:26–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stefansson OA and Esteller M: Epigenetic
modifications in breast cancer and their role in personalized
medicine. Am J Pathol. 183:1052–1063. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baxter E, Windloch K, Gannon F and Lee JS:
Epigenetic regulation in cancer progression. Cell Biosci. 4:452014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Atalay C: Epigenetics in breast cancer.
Exp Oncol. 35:246–249. 2013.PubMed/NCBI
|
|
7
|
Andersen GB and Tost J: A summary of the
biological processes, disease-associated changes, and clinical
applications of DNA methylation. Methods Mol Biol. 1708:3–30. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baylin SB, Esteller M, Rountree MR,
Bachman KE, Schuebel K and Herman JG: Aberrant patterns of DNA
methylation, chromatin formation and gene expression in cancer. Hum
Mol Genet. 10:687–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ehrlich M: DNA methylation in cancer: Too
much, but also too little. Oncogene. 21:5400–5413. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye D, Jiang D, Li Y, Jin M and Chen K: The
role of LINE-1 methylation in predicting survival among colorectal
cancer patients: A meta-analysis. Int J Clin Oncol. 22:749–757.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Szyf M, Pakneshan P and Rabbani SA: DNA
methylation and breast cancer. Biochem Pharmacol. 68:1187–1197.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Y, Joyce BT, Liu L, Zhang Z, Kibbe
WA, Zhang W and Hou L: Prediction of genome-wide DNA methylation in
repetitive elements. Nucleic Acids Res. 45:8697–8711. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo Y, Lu X and Xie H: Dynamic Alu
methylation during normal development, aging, and tumorigenesis.
Biomed Res Int. 2014:7847062014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie H, Wang M, Bonaldo Mde F, Smith C,
Rajaram V, Goldman S, Tomita T and Soares MB: High-throughput
sequence-based epigenomic analysis of Alu repeats in human
cerebellum. Nucleic Acids Res. 37:4331–4340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmid CW: Human Alu subfamilies and their
methylation revealed by blot hybridization. Nucleic Acids Res.
19:5613–5617. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Phokaew C, Kowudtitham S, Subbalekha K,
Shuangshoti S and Mutirangura A: LINE-1 methylation patterns of
different loci in normal and cancerous cells. Nucleic Acids Res.
36:5704–5712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoder JA, Walsh CP and Bestor TH: Cytosine
methylation and the ecology of intragenomic parasites. Trends
Genet. 13:335–340. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoffmann MJ and Schulz WA: Causes and
consequences of DNA hypomethylation in human cancer. Biochem Cell
Biol. 83:296–321. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bae JM, Shin SH, Kwon HJ, Park SY, Kook
MC, Kim YW, Cho NY, Kim N, Kim TY, Kim D and Kang GH: ALU and
LINE-1 hypomethylations in multistep gastric carcinogenesis and
their prognostic implications. Int J Cancer. 131:1323–1331. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saito K, Kawakami K, Matsumoto I, Oda M,
Watanabe G and Minamoto T: Long interspersed nuclear element 1
hypomethylation is a marker of poor prognosis in stage IA non-small
cell lung cancer. Clin Cancer Res. 16:2418–2426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Antelo M, Balaguer F, Shia J, Shen Y, Hur
K, Moreira L, Cuatrecasas M, Bujanda L, Giraldez MD, Takahashi M,
et al: A high degree of LINE-1 hypomethylation is a unique feature
of early-onset colorectal cancer. PLoS One. 7:e453572012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dammann RH, Kirsch S, Schagdarsurengin U,
Dansranjavin T, Gradhand E, Schmitt WD and Hauptmann S: Frequent
aberrant methylation of the imprinted IGF2/H19 locus and LINE1
hypomethylation in ovarian carcinoma. Int J Oncol. 36:171–179.
2010.PubMed/NCBI
|
|
24
|
van Hoesel AQ, van de Velde CJ, Kuppen PJ,
Liefers GJ, Putter H, Sato Y, Elashoff DA, Turner RR, Shamonki JM,
de Kruijf EM, et al: Hypomethylation of LINE-1 in primary tumor has
poor prognosis in young breast cancer patients: A retrospective
cohort study. Breast Cancer Res Treat. 134:1103–1114. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi IS, Estecio MR, Nagano Y, Kim DH,
White JA, Yao JC, Issa JPJ and Rashid A: Hypomethylation of LINE-1
and Alu in well-differentiated neuroendocrine tumors (pancreatic
endocrine tumors and carcinoid tumors). Mod Pathol. 20:802–810.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park SY, Seo AN, Jung HY, Gwak JM, Jung N,
Cho NY and Kang GH: Alu and LINE-1 hypomethylation is associated
with HER2 enriched subtype of breast cancer. PLoS One.
9:e1004292014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bakshi A, Herke SW, Batzer MA and Kim J:
DNA methylation variation of human-specific Alu repeats.
Epigenetics. 11:163–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC,
Cho YM, Kim D and Kang GH: Hypermethylation of CpG island loci and
hypomethylation of LINE-1 and Alu repeats in prostate
adenocarcinoma and their relationship to clinicopathological
features. J Pathol. 211:269–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwon HJ, Kim JH, Bae JM, Cho NY, Kim TY
and Kang GH: DNA methylation changes in ex-adenoma carcinoma of the
large intestine. Virchows Arch. 457:433–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chalitchagorn K, Shuangshoti S, Hourpai N,
Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N,
Sriuranpong V and Mutirangura A: Distinctive pattern of LINE-1
methylation level in normal tissues and the association with
carcinogenesis. Oncogene. 23:8841–8846. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shigaki H, Baba Y, Watanabe M, Murata A,
Iwagami S, Miyake K, Ishimoto T, Iwatsuki M and Baba H: LINE-1
hypomethylation in gastric cancer, detected by bisulfite
pyrosequencing, is associated with poor prognosis. Gastric Cancer.
16:480–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Khakpour G, Pooladi A, Izadi P, Noruzinia
M and Tavakkoly Bazzaz J: DNA methylation as a promising landscape:
A simple blood test for breast cancer prediction. Tumour Biol.
36:4905–4912. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wong JY, De Vivo I, Lin X, Grashow R,
Cavallari J and Christiani DC: The association between global DNA
methylation and telomere length in a longitudinal study of
boilermakers. Genet Epidemiol. 38:254–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Busato F, Dejeux E, El Abdalaoui H, Gut IG
and Tost J: Quantitative DNA methylation analysis at
single-nucleotide resolution by pyrosequencing(R). Methods Mol
Biol. 1708:427–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsumoto A, Jinno H, Ando T, Fujii T,
Nakamura T, Saito J, Takahashi M, Hayashida T and Kitagawa Y:
Biological markers of invasive breast cancer. Jpn J Clin Oncol.
46:99–105. 2016.PubMed/NCBI
|
|
36
|
Malhotra GK, Zhao X, Band H and Band V:
Histological, molecular and functional subtypes of breast cancers.
Cancer Biol Ther. 10:955–960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Levenson VV: DNA methylation as a
universal biomarker. Expert Rev Mol Diagn. 10:481–488. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ronaghi M: Pyrosequencing sheds light on
DNA sequencing. Genome Res. 11:3–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tost J and Gut IG: DNA methylation
analysis by pyrosequencing. Nat Protoc. 2:2265–2275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Erichsen L, Beermann A, Arauzo-Bravo MJ,
Hassan M, Dkhil MA, Al-Quraishy S, Hafiz TA, Fischer JC and
Santourlidis S: Genome-wide hypomethylation of LINE-1 and Alu
retroelements in cell-free DNA of blood is an epigenetic biomarker
of human aging. Saudi J Biol Sci. 25:1220–1226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hancks DC and Kazazian HH Jr: Roles for
retrotransposon insertions in human disease. Mob DNA. 7:92016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Deininger PL and Batzer MA: Alu repeats
and human disease. Mol Genet Metab. 67:183–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ross JP, Rand KN and Molloy PL:
Hypomethylation of repeated DNA sequences in cancer. Epigenomics.
2:245–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kuan TC, Lin PC, Yang SH, Lin CC, Lan YT,
Lin HH, Liang WY, Chen WS, Lin JK, Jiang JK and Chang SC: Impact of
LINE-1 hypomethylation on the clinicopathological and molecular
features of colorectal cancer patients. PLoS One. 13:e01976812018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Estecio MR, Gharibyan V, Shen L, Ibrahim
AEK, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang THM, et al:
LINE-1 hypomethylation in cancer is highly variable and inversely
correlated with microsatellite instability. PLoS One. 2:e3992007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Woraruthai T, Charoenlap C, Hongsaprabhas
C, Mutirangura A and Honsawek S: Alu hypermethylation and high
oxidative stress in patients with musculoskeletal tumors. PeerJ.
6:e54922018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Michels KB, Harris HR and Barault L:
Birthweight, maternal weight trajectories and global DNA
methylation of LINE-1 repetitive elements. PLoS One. 6:e252542011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kupcinskas J, Steponaitiene R, Langner C,
Smailyte G, Skieceviciene J, Kupcinskas L, Malfertheiner P and Link
A: LINE-1 hypomethylation is not a common event in preneoplastic
stages of gastric carcinogenesis. Sci Rep. 7:48282017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ogino S, Kawasaki T, Nosho K, Ohnishi M,
Suemoto Y, Kirkner GJ and Fuchs CS: LINE-1 hypomethylation is
inversely associated with microsatellite instability and CpG island
methylator phenotype in colorectal cancer. Int J Cancer.
122:2767–2773. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schernhammer ES, Giovannucci E, Kawasaki
T, Rosner B, Fuchs CS and Ogino S: Dietary folate, alcohol and B
vitamins in relation to LINE-1 hypomethylation in colon cancer.
Gut. 59:794–799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sigurdsson MI, Smith AV, Bjornsson HT and
Jonsson JJ: Distribution of a marker of germline methylation
differs between major families of transposon-derived repeats in the
human genome. Gene. 492:104–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kochanek S, Renz D and Doerfler W: DNA
methylation in the alu sequences of diploid and haploid primary
human cells. EMBO J. 12:1141–1151. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Weber B, Kimhi S, Howard G, Eden A and
Lyko F: Demethylation of a LINE-1 antisense promoter in the cMet
locus impairs Met signalling through induction of illegitimate
transcription. Oncogene. 29:5775–5784. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cho YH, Yazici H, Wu HC, Terry MB,
Gonzalez K, Qu M, Dalay N and Santella RM: Aberrant promoter
hypermethylation and genomic hypomethylation in tumor, adjacent
normal tissues and blood from breast cancer patients. Anticancer
Res. 30:2489–2496. 2010.PubMed/NCBI
|
|
55
|
Chen J, Huan W, Zuo H, Zhao L, Huang C,
Liu X, Hou S, Qi J and Shi W: Alu methylation serves as a biomarker
for non-invasive diagnosis of glioma. Oncotarget. 7:26099–26106.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wu HC, Delgado-Cruzata L, Flom JD, Perrin
M, Liao Y, Ferris JS, Santella RM and Terry MB: Repetitive element
DNA methylation levels in white blood cell DNA from sisters
discordant for breast cancer from the New York site of the breast
cancer family registry. Carcinogenesis. 33:1946–1952. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cao X, Holland-Letz T, Tang Q, Li X,
Gündert M, Cuk K, Schott S, Heil J, Golatta M and Sohn C:
Investigation of global methylation in peripheral blood from breast
cancer patients. J Mol Biomark Diagn.
doi:10.4172/2155-9929.S2-037.
|
